96228 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF
#2SMALL MOLECULE COMPOUNDS WITH PHOSPHORYLATED ARYL STRUCTURES AND USE THEREOF
#3HETEROCYCLIC COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL USE THEREOF
#4STAT6 COMPOUNDS
#5COMPOUNDS FOR MODULATING HUR (ELAVL1)
#6Heteroaryl compounds as inhibitors of TYK2/JAK1, composition and application thereof
#7STING AGONIST COMPOUNDS
#8ANTI-HIV COMPOUNDS
#9PYRAZOLE COMPOUNDS AND METHOD FOR MAKING AND USING THE COMPOUNDS
#10POLYMERIC TANDEM DYES WITH LINKER GROUPS
#11HETEROCYCLIC DERIVATIVES AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS
#12DIDEHYDRO-3'-DEOXY-4'-ETHYNYLTHYMIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
#13EGFR DEGRADATION AGENT
#14PHOSPHORUS PRODRUGS OF PYRAZOLO-SUBSTITUTED PYRIMIDINE sGC STIMULATORS
#15CARBOCYCLIC NUCLEOSIDE, OLIGONUCLEOTIDE AND PREPARATION METHODS THEREFOR AND MEDICAL USES THEREOF
#16SYNTHETIC GLYCEROPHOSPHOLIPIDS COMPRISING AT LEAST ONE REACTIVE FUNCTION, PROCESS FOR PREPARING SAME AND USES THEREOF IN DIFFERENT APPLICATIONS
#17CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer
#18POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION
#19ANTIVIRAL PRODRUGS, INTERMEDIATE-AND LONG-ACTING FORMULATIONS AND METHODS
#20CRYSTAL FORM OF ISOCHROMAN COMPOUND
#21FUSED HETEROCYCLIC COMPOUNDS AS PI3KALPHA INHIBITORS
#22ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUES
#23APT1 and APT2 Inhibitors and Uses Thereof
#24SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AND METHODS OF USE THEREOF
#25Synthesis Process of X-IPM, Stable Crystal Form and Application Thereof
#26COMPOUNDS TARGETING MUTANT OF P53
#27SYNTHESIS OF BACKBONE MODIFIED MORPHOLINO OLIGONUCLEOTIDES AND CHIMERAS USING PHOSPHORAMIDITE CHEMISTRY
#28MASKED FLUOROGENIC LIPID COMPOUNDS, LIPID PARTICLES COMPRISING THE SAME, AND METHODS OF USE THEREOF
#29SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF
#30CYCLIN K DEGRADER
#31PHOSPHORUS PRODRUGS OF PYRAZOLO-SUBSTITUTED PYRIMIDINE SGC STIMULATORS
#32THIOL-CONJUGATION WITH UNSATURATED PHOSPHORUS(V) COMPOUNDS
#33AUTOMATED SYNTHESIS OF POLYMERIC DRUGS
#34NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES
#35NOVEL BICYCLIC NUCLEOSIDES AND OLIGOMERS PREPARED THEREFROM
#36Heteroaryl compounds as inhibitors of TYK2, composition and application thereof
#37CYCLIC-DISULFIDE MODIFIED PHOSPHATE BASED OLIGONUCLEOTIDE PRODRUGS
#38ASYMMETRIC GPR84 ANTAGONIST AND USE THEREOF
#39Base-Modified Cytidine Nucleotides for Leukemia Therapy
#40POLYMERIC TANDEM DYES WITH LINKER GROUPS
#41nSMASE2 INHIBITOR PRODRUGS WITH ENHANCED ORAL AND BRAIN EXPOSURES
#42Compound containing phosphate group, pharmaceutical composition containing same, preparation method therefor and use thereof
#43NOVEL PYRIMIDINE DERIVATIVE AND USE THEREOF
#44ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS
#45ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS
#46POLYNUCLEOTIDE CONSTRUCTS
#47PHOSPHORUS PRODRUGS OF PYRAZOLO-SUBSTITUTED PYRIMIDINE SGC STIMULATORS
#48PRODRUGS OF L-BHDU AND METHODS OF TREATING VIRAL INFECTIONS
#49GLP-1R MODULATING COMPOUNDS
#50FUSED RING COMPOUND AS WEE-1 INHIBITOR
#51MODIFIED ADENINES
#52Organic Semiconductive Layer Comprising Phosphine Oxide Compounds
#53PHOSPHORUS PRODRUGS OF PYRAZOLO-SUBSTITUTED PYRIMIDINE SGC STIMULATORS
#54AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF
#55AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
#56DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER
#57ISOCHROMAN COMPOUND
#58NOVEL PYRIMIDINE DERIVATIVE AND USE THEREOF
#59ARYL PHOSPHOROUS OXIDE COMPOUNDS AND USE THEREOF
#60STAT5 and STAT6 Inhibitors and Uses Thereof
#61HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
#62ZWITTERIONIC COMPOUND, PRODUCING METHOD THEREOF, POLYMER THEREOF, AND CONDUCTIVE STRUCTURE
#63CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
#64IMMUNOMODULATOR
#65NOVEL AMINOPYRIMIDINE EGFR INHIBITOR
#66Protected fluorescent reagent compounds
#67Prodrugs of L-BHDU and methods of treating viral infections
#68Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancer
#69SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES
#70Nicotinamide mononucleotide derivatives and their uses
#71ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS
#72DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER
#73Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
#74GLP-1R modulating compounds
#75Therapeutics for the treatment of glaucoma
#76BIARYL COMPOUND AS PAN-RAF KINASE INHIBITOR
#77PHOSPHATE DERIVATIVES OF RORGAMMA MODULATORS AND USES THEREOF
#78DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE
#79URIDINE DIPHOSPHATE DERIVATIVES, PRODRUGS, COMPOSITIONS AND USES THEREOF
#80RAPID, HIGH-INTENSITY CHEMILUMINESCENT DIOXETANES
#81Polymeric tandem dyes with linker groups
#82HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
#83CONTROLLED-DELIVERY CROMAKALIM PRODRUGS
#84PYRAZOLE COMPOUNDS AND METHODS FOR MAKING AND USING THE COMPOUNDS
#85HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#86Phosphatidylinositol 3-kinase inhibitors
#87CD73 INHIBITORS
#88STAT3 PROTEIN DEGRADERS
#89HIGH-AFFINITY CU(I) LIGANDS AND METHODS OF USE THEREOF
#90Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry
#91Functionally-Modified Oligonucleotides And Subunits Thereof
#92Bicyclic nucleosides and oligomers prepared therefrom
#93COMPOUNDS USEFUL AS INHIBITORS OF ALCAT 1
#94Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#95CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS
#96METABOLICALLY STABLE PRODRUGS
#97Phenylpyrrolidinone formyl peptide 2 receptor agonists
#98URIDINE DIPHOSPHATE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
#99CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
#100IONIC TAGS FOR SYNTHESIS OF OLIGORIBONUCLEOTIDES
#101Alvocidib Prodrugs Having Increased Bioavailability
#102Base-Modified Cytidine Nucleotides for Leukemia Therapy
#103Polymeric tandem dyes with linker groups
#104Beta-nicotinate ester nucleotides and processes for preparing same
#105Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases
#106BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS
#107Protected fluorescent reagent compounds
#108POSACONAZOLE PHOSPHATE MONOCHOLINATE, PREPARATION METHOD AND USE THEREOF
#109Skeletal removal of bisphosphonates
#110Ultra bright dimeric or polymeric dyes with spacing linker groups
#111Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#112Dioxolane analogues of uridine for the treatment of cancer
#113Therapeutics for the treatment of glaucoma
#114NANOPARTICLE COMPOSITIONS
#115Salts of prodrugs of piperazine and substituted piperidine antiviral agents
#116Nitrobenzyl derivatives of anti-cancer agents
#117Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
#118Organophosphate derivatives
#119Nicotinamide mononucleotide derivatives and their uses
#120Conjoint Therapies with Inhibitors of Glucose Production
#121Cyclic peroxides as prodrugs for selective delivery of agents
#122PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#123Ultra bright dimeric or polymeric dyes with spacing linker groups
#124Solid supports and phosphoramidite building blocks for oligonucleotide conjugates
#125CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
#126Phenylpyrrolidinone formyl peptide 2 receptor agonists
#127Dioxolane analogues of uridine for the treatment of cancer
#128Organic electronic device comprising an organic semiconductor layer
#129ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
#130Functionally-modified oligonucleotides and subunits thereof
#131Compounds useful as inhibitors of ALCAT 1
#132Heteroaryl compounds useful as inhibitors of SUMO activating enzyme
#133Aziridine containing DNA alkylating agents
#134Nucleotides comprising an N-[(S)-1-cyclobutoxycarbonyl]phosphoramidate moiety and analogs and application thereof
#135PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#136Alvocidib prodrugs and their use as protein kinase inhibitors
#137SALTS OF PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS
#138β-nicotinate ester nucleotides and process for preparing same
#139Dioxolane analogues of uridine for the treatment of cancer
#140Prodrug of an HCV NS5B polymerase inhibitor and method of production and application thereof
#141CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES
#142Bicyclic nucleosides and oligomers prepared therefrom
#143Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
#144Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators
#145Cyclic peroxides as prodrugs for selective delivery of agents
#146Sorbitol, glucaric acid, and gluconic acid based flame-retardants
#147Phenylpyrrolidinone formyl peptide 2 receptor agonists
#148ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
#149Non-halogenated flame retardant hindered amine light stabilizer cross-linkers
#150P-chiral phosphine ligands and use thereof for asymmetric synthesis
#151Skeletal removal of bisphosphonates
#152Polynucleotide constructs
#153Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#154Alvocidib prodrugs having increased bioavailability
#155Compound for electron-transport material and organic light emitting diode including the same
#156Pyrazole compounds and methods for making and using the compounds
#157Acylphosphine oxide photoinitiators
#158Flame-retardant vanillin-derived cross-linkers
#159Compositions comprising a polymeric dye and a cyclodextrin and uses thereof
#160Heterocyclic compound and organic light-emitting device including the same
#161Ultraviolet light stabilizing polymeric filler materials
#162SALTS OF PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS
#163Dioxolane analogues of uridine for the treatment of cancer
#164Method for producing P,P-di(uridine 5′-) tetraphosphate
#165Ionic tags for synthesis of oligoribonucleotides
#166Sorbitol, glucaric acid, and gluconic acid based flame-retardants
#167Posaconazole derivative, pharmaceutical composition and use thereof
#168Delivery systems for controlled drug release
#169Organic electron transport material and organic electroluminescent element using same
#170Cross-linkable flame retardant materials
#171N-HYDROXYFORMAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THEM FOR USE AS BMP l, TLL1 AND/OR TLL2 INHIBITORS
#172Protected fluorescent reagent compounds
#173BONE TARGETED THERAPEUTICS AND METHODS OF MAKING AND USING THE SAME
#174Organic semiconductive layer comprising phosphine oxide compounds
#175Bortezomib conjugates and methods using same
#176Heteroaryl compounds useful as inhibitors of sumo activating enzyme
#177Synthesis of phosphoramidates
#178Furan-containing flame retardant molecules
#179Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#180Polynucleotides containing a stabilizing tail region
#181Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
#182Organic compound, electrochromic element, optical filter, lens unit, image pickup apparatus, and window member
#183Functionally-modified oligonucleotides and subunits thereof
#184Dyes with phosphinic acid, phosphinate, phosphonate and phosphonamidate substituents as auxochromic groups and methods for preparing the same
#185Pyrazole compounds and method for making and using the compounds
#186Pyrazole compounds and method for making and using the compounds
#187SUBSTITUTED OXOTETRAHYDROQUINOLINYLPHOSPHINIC ACID AND PHOSPHINIC ACID AMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS
#188Ultra bright dimeric or polymeric dyes with spacing linker groups
#189Cross-linkable flame retardant materials
#190SUBSTITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS
#191Serine/threonine kinase inhibitors
#192Process for making phosphoramidate protected nucleoside compounds
#193Nitrobenzyl derivatives of anti-cancer agents
#194SOFOSBUVIR IN CRYSTALLINE FORM AND PROCESS FOR ITS PREPARATION
#195Condensed-cyclic compound and organic light-emitting device comprising the same
#196Fumagillol derivatives
#197Electrochromic compound, electrochromic composition, electrochromic element, and electrochromic dimming element
#198NUCLEOSIDE PHOSPHORAMIDATES
#199Phosphoramidate nucleoside prodrug for treating viral diseases and cancer, processes for their preparation and their use
#200Crystalline fosaprepitant dicyclohexylamine salt and its preparation
#201Solid supports and phosphoramidite building blocks for oligonucleotide conjugates
#202SALTS OF PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS
#203Alvocidib prodrugs having increased bioavailability
#204Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#205Method of biotransformation of benzopyrone compounds into the corresponding phosphate-conjugated derivatives
#206Di- and triphosphate prodrugs
#207Substituted phosphoramidate compounds and uses thereof
#208Dioxolane analogues of cytidine for the treatment of cancer
#209Functionalizing nanofibres
#210Heterocycle-substituted xanthene dyes
#211Aminopyrimidine kinase inhibitors
#212Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
#2132' FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT
#214PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#215Heteroaryl compounds useful as inhibitors of SUMO activating enzyme
#2165′-dibenzyl phosphates of 5-azacytidine or 2′-deoxy-5-azacytidine
#217Substituted nucleosides, nucleotides and analogs thereof
#218Alternative nucleic acid molecules and uses thereof
#219Monomers and oligonucleotides comprising cycloaddition adduct(s)
#220KLK4 inhibitors
#221Solid composition comprising amorphous sofosbuvir
#222Activators of glucokinase
#223Sofosbuvir in crystalline form and process for its preparation
#224NOVEL ANNELATED PHENOXYACETAMIDES
#225Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
#226SUBSTITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS
#227Condensed cyclic compound and organic light-emitting device including the same
#228Therapeutics for the treatment of glaucoma
#229Functionally-modified oligonucleotides and subunits thereof
#230Phosphorous Derivatives as Kinase Inhibitors
#231Crystalline fosaprepitant dicyclohexylamine salt and its preparation
#232Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device
#233Alvocidib prodrugs having increased bioavailability
#234Carboxy X rhodamine analogs
#235Urea derivatives useful as kinase inhibitors
#236Pyrazole compounds and method for making and using the compounds
#237Functionalizing nanofibres
#238Condensed cyclic compound and organic light-emitting device comprising the same
#239Phosphonate derivatives and methods of use thereof in the treatment of Alzheimer's disease
#240Compounds for inhibiting cell proliferation in EGFR-driven cancers
#241Uridine diphosphate derivatives, prodrugs, compositions and methods for treating neurodegenerative disorders
#242Method for producing P1,P4-di(uridine 5′-) tetraphosphate
#243Fumagillol derivatives
#244Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#245Compounds and methods for trans-membrane delivery of molecules
#246FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES
#247Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#248Serine/threonine kinase inhibitors
#249Compound and organic light-emitting device including the same
#250PHOSPHORIC ACID/PHOSPHONIC ACID DERIVATIVES AND MEDICINAL USES THEREOF
#251Monomers and oligonucleotides comprising cycloaddition adduct(s)
#252Bone targeted therapeutics and methods of making and using the same
#253Condensed cyclic compound and organic light-emitting device including the same
#254Organic electroluminescent element, and lighting device and display device which are provided with same
#255S1P receptors modulators and their use thereof
#256Benzothiophene derivative
#257Modified nucleic acid
#258Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
#259Hepatitis C inhibitors and uses thereof
#260Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
#261Process for preparing 3-[(45)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
#262Substituted nucleosides, nucleotides and analogs thereof
#263Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
#264Material for organic electroluminescent element, organic electroluminescent element, illumination device, and display device
#265Disulfide masked prodrug compositions and methods
#266Nucleoside kinase bypass compositions and methods
#267Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#268Carboxy X rhodamine analogs
#269Inhibitors of protein tyrosine phosphatases
#270Herbicidally and fungicidally active 3-heteroaryl-isoxazoline-5-carboxamides and 3-heteroaryl-isoxazoline-5-thioamides
#271Aminopyrimidine kinase inhibitors
#272Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#273Solid forms of an antiviral compound
#274Activators of glucokinase
#275Moenomycin analogs, methods of synthesis, and uses thereof
#276Amine compound and use thereof for medical purposes
#277Compositions and methods for the treatment of metabolic syndrome
#278Spiro[2.4]heptanes for treatment of Flaviviridae infections
#279Phosphonate derivatives and methods of use thereof in the treatment of Alzheimer's disease
#280Protected fluorescent reagent compounds
#281Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
#282Functionally-modified oligonucleotides and subunits thereof
#283Triazole compounds that modualte HSP90 activity
#284FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES
#285Ionic tags for synthesis of oligoribonucleotides
#286Compounds and pharmaceutical compositions for the treatment of viral infections
#287Serine/threonine kinase inhibitors
#288PURINE MONOPHOSPHATE PRODRUGS FOR TREATMENT OF VIRAL INFECTIONS
#2896,11-BRIDGED BIARYL MACROLIDES
#290Methods for treating glaucoma using uridine diphosphate derivatives
#291Spiro[2.4]heptanes for treatment of flaviviridae infections
#2922-thio-1,3,4-oxadiazoles derivatives as sphingosine-1 phosphate receptors modulators
#293MACROCYCLIC PRODRUG COMPOUNDS USEFUL AS THERAPEUTICS
#294Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
#295Nucleoside phosphoramidates
#296Compounds as receptor modulators with therapeutic utility
#297Cold menthol receptor-1 antagonists
#298BIFUNCTIONAL CHELATING AGENTS
#299Phenicol antibacterial agents
#300Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders